iShares SMIM ETF (CH) is an exchange-traded fund that seeks to track the performance of the SMIM® index, comprising the 30 largest and most liquid Swiss mid-cap companies excluded from the broader SMI index. Launched on December 8, 2004, and domiciled in Switzerland, it provides investors with targeted exposure to mid-sized Swiss equities across key sectors such as financials, consumer goods, healthcare, and industrials. The fund employs a physical replication strategy, holding all index constituents to mirror their weightings, with a total expense ratio of 0.45% per annum. It distributes dividends at least annually and maintains a focused portfolio of exactly 30 holdings, including prominent names like Sandoz Group AG and Galderma Group AG in healthcare, alongside industrials like SGS AG. With net assets exceeding CHF 1.1 billion, iShares SMIM ETF (CH) plays a vital role in the Swiss financial market by offering a cost-effective vehicle for accessing the dynamic mid-cap segment, which often exhibits growth potential distinct from large-cap benchmarks. Its market capitalization weighting and liquidity focus enhance its appeal for those seeking diversified Swiss equity exposure beyond blue-chip giants.